EUVIMEDEUVIMED entdecken
Crossref

Dual-Targeted Thalidomide Nanoliposomes Suppress Neutrophil-Driven Inflammation in Intestinal Behçet’s Disease

Rou Tang, Fujun Zeng, Shuo Chen, Kaichao Song, Yige Yang, Ya Meng, Xiaochuan Tan, Peng Lei, Kun He, Lu Lu, Shuwang He, Yujia Zhang und 3 weitere

ACS Applied Materials & Interfaces · 17.11.2026

DOI: 10.1021/acsami.6c15386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 17.11.2026. Verfasst von Rou Tang und 14 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Peking Union Medical College, Beijing Municipal Natural Science Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excessive neutrophil recruitment, vascular activation, and platelet-associated inflammatory interfaces are implicated in intestinal tissue injury in intestinal Behçet’s disease (intestinal BD), whereas conventional systemic therapies offer limited spatial control over drug exposure within active intestinal lesions. Here, we developed thalidomide-loaded nanoliposomes co-functionalized with a neutrophil elastase-binding peptide (NEBP) and a P-selectin-binding peptide (PSN), designated Thd-NEBP/PSN-Lip, to engage complementary activated neutrophil-associated and P-selectin-associated inflammatory interfaces. Thd-NEBP/PSN-Lip exhibited a mean hydrodynamic diameter of 116.6 ± 5.7 nm, a thalidomide encapsulation efficiency of 91.43 ± 0.71%, and reduced initial burst release, while maintaining colloidal stability during storage and simulated gastrointestinal exposure. Surface ligand density was estimated from the feed composition. Ligand-dependent interactions were observed in activated endothelial cells and neutrophil-like cells; in activated endothelial cells, liposome-associated fluorescence increased from 7.42% for Thd-Lip to 40.55% for Thd-NEBP/PSN-Lip and decreased to 1.10% following free PSN competition. Additional validation supported PSN-dependent association with activated platelets and greater inflamed-tissue association of the dual-ligand formulation than with either single-ligand formulation. In vivo, Thd-NEBP/PSN-Lip showed preferential and prolonged retention within inflamed intestinal tissues, with intestinal fluorescence remaining approximately 2.6-fold higher than that of Thd-Lip at 24 h. LC–MS/MS quantification further showed increased total intestinal thalidomide exposure and a higher intestine/plasma concentration ratio after Thd-NEBP/PSN-Lip administration. In a murine intestinal BD-like model, Thd-NEBP/PSN-Lip alleviated intestinal injury, restored colon length toward the healthy level, reduced neutrophil infiltration and local inflammatory cytokine expression, attenuated responses involving IL-17A+CD4+ and IFN-γ+CD4+ T cells, and partially restored the Foxp3+ regulatory T cell compartment. Microbiome, metabolomic, and transcriptomic analyses further indicated broader treatment-associated changes in the intestinal inflammatory microenvironment. Collectively, these findings suggest that dual-targeted nanoliposomes improve lesion-directed thalidomide delivery and suppress neutrophil-driven intestinal inflammation, supporting a pathology-guided nanotherapeutic strategy for intestinal BD.

Förderung

  • Peking Union Medical College
  • Beijing Municipal Natural Science Foundation

Zitieren

APA

Tang, R., Zeng, F., Chen, S., Song, K., Yang, Y., Meng, Y., Tan, X., Lei, P., He, K., Lu, L., He, S., Zhang, Y., Wu, D., Li, Z., & Zheng, W. (2026). Dual-Targeted Thalidomide Nanoliposomes Suppress Neutrophil-Driven Inflammation in Intestinal Behçet’s Disease. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c15386

Vancouver

Tang R, Zeng F, Chen S, Song K, Yang Y, Meng Y, et al. Dual-Targeted Thalidomide Nanoliposomes Suppress Neutrophil-Driven Inflammation in Intestinal Behçet’s Disease. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c15386

BibTeX
@article{Tang2026,
  author = {Tang, Rou and Zeng, Fujun and Chen, Shuo and Song, Kaichao and Yang, Yige and Meng, Ya and Tan, Xiaochuan and Lei, Peng and He, Kun and Lu, Lu and He, Shuwang and Zhang, Yujia and Wu, Dong and Li, Zhenhua and Zheng, Wensheng},
  title = {Dual-Targeted Thalidomide Nanoliposomes Suppress Neutrophil-Driven Inflammation in Intestinal Behçet’s Disease},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c15386}
}
Kostenlos starten →